The Global Pharmaceutical Market Case Study

The Global Pharmaceutical Market Case Study

Table of Contents

Order ID# 45178248544XXTG457	Plagiarism Level: 0-0.5%	Writer Classification: PhD competent
Style: APA/MLA/Harvard/Chicago	Delivery: Minimum 3 Hours	Revision: Permitted
Sources: 4-6	Course Level: Masters/University College	Guarantee Status: 96-99%

Instructions

The Global Pharmaceutical Market Case Study

Demand for pharmaceuticals is driven by the desire to cure illness and disease. The profitability of individual companies depends on their ability to discover and market new drugs.

Large companies benefit from their economies of scale in research, manufacturing, and marketing. Small companies can compete effectively by specializing in drugs that target one or two specific ailments.

The Unites States (U.S.) industry is highly concentrated: the 50 largest companies account for more than 80 percent of revenue. The global pharmaceutical market is growing steadily, with sales reaching $1.08 trillion in 2011 – a year-on-year increase of 7.8% (PWC, 2012).

Modern drug development is an outgrowth of recent research into the specific causes of illness and disease, coupled with advances in chemistry and industrial technology that allow scientists to manufacture chemicals to improve these conditions.

The explosion of scientific knowledge about human biology in the past 40 years has provided a wide array of advancements in medications.

Tomorrow’s challenge is to develop new medicines that can prevent or cure currently incurable diseases. Today’s challenge is to get to tomorrow – and that’s a tall order in itself.

Health care payers are imposing new cost constraints on providers and are scrutinizing the value of medicines more carefully.

Health care expenditure as a percentage of gross domestic product (GDP) is climbing in countries in every income bracket, and it’s climbing most steeply in the mature global markets where the Pharma industry has historically made most of its money. That includes the U.S.

The paramount challenge is to create more value for patients, providers and payers. What thoughts and ideas do you have in order for the Pharma industry to do so? Think about all you read in Chapters 5, 10 and 12 (and the others last week).

Think about the current economic, social, demographic, medical, technical and political influences and trends when responding.

Consider the newer and older reimbursement models as well as the changing models of care and focus on quality currently seen in health care today.  Support and explain your position as to how the pharmacy industry can reinvent itself to benefit the key stakeholders.

References

PwC (2012). From Vision to Decision, Pharma 2020. Retrieved from http://www.pwc.com/en_GX/gx/pharma-life-sciences/pharma2020/assets/pwc-pharma-success-strategies.pdf

Health_Care_Economics_Chapter12.pdf

Health_Care_Economics_Chapter05.pdf

Health_Care_Economics_Chapter10.pdf

The Global Pharmaceutical Market Case Study

RUBRIC
Excellent Quality 95-100%	Introduction 45-41 points The background and significance of the problem and a clear statement of the research purpose is provided. The search history is mentioned.		Literature Support 91-84  points The background and significance of the problem and a clear statement of the research purpose is provided. The search history is mentioned.			Methodology 58-53 points Content is well-organized with headings for each slide and bulleted lists to group related material as needed. Use of font, color, graphics, effects, etc. to enhance readability and presentation content is excellent. Length requirements of 10 slides/pages or less is met.
Average Score 50-85%	40-38 points More depth/detail for the background and significance is needed, or the research detail is not clear. No search history information is provided.		83-76  points Review of relevant theoretical literature is evident, but there is little integration of studies into concepts related to problem. Review is partially focused and organized. Supporting and opposing research are included. Summary of information presented is included. Conclusion may not contain a biblical integration.			52-49  points Content is somewhat organized, but no structure is apparent. The use of font, color, graphics, effects, etc. is occasionally detracting to the presentation content. Length requirements may not be met.
Poor Quality 0-45%	37-1 points The background and/or significance are missing. No search history information is provided.		75-1 points Review of relevant theoretical literature is evident, but there is no integration of studies into concepts related to problem. Review is partially focused and organized. Supporting and opposing research are not included in the summary of information presented. Conclusion does not contain a biblical integration.			48-1 points There is no clear or logical organizational structure. No logical sequence is apparent. The use of font, color, graphics, effects etc. is often detracting to the presentation content. Length requirements may not be met
You Can Also Place the Order at www.perfectacademic.com/orders/ordernow or www.crucialessay.com/orders/ordernow The Global Pharmaceutical Market Case Study

The Global Pharmaceutical Market Case Study

PLACE THE ORDER WITH US TODAY AND GET A PERFECT SCORE!!!